Abstract:ABSTRACT Background The development of effective treatments for multiple sclerosis (MS), and in particular its progressive forms, is hampered by the lack of etiologically relevant cellular and animal models of human disease. Models that recapitulate the biological and pathological processes leading to the onset and progression of MS in patients are likely to afford better translational efficacy. Following the discovery of the NR1H3 p.Arg415Gln pathogenic mutation for progressive MS in two Canadian families, we developed a knock-in mouse model harboring a homologous mutation in the endogenous gene to provide a more physiologically relevant model of human MS. Methods Gene expression was evaluated in constitutive heterozygote (which recapitulates the human disease genotype) and homozygote Nr1h3 p.Arg413Gln knock-in mice on a C57BL/6 background, and compared to wild-type littermates. AmpliSeq Transcriptome Mouse Gene Expression kits analyzed on an Ion Proton sequencer were used to generate the gene expression profiles of spleen, liver, brain and spinal cord tissue from three-month-old male and female mice. Differential expression between genotypes was assessed with DESeq2, and Gene Ontologies pathways enrichment analysis performed with DAVID v6.8. Benjamini-Hochberg false discovery rate (FDR) correction for multiple testing was applied. Results Transcriptome analysis of spleen tissue from Nr1h3 p.Arg413Gln mice revealed 23 significantly dysregulated genes (FDR<0.05) with greater than a two-fold change in expression. These include CD5 antigen-like ( Cd5l ), complement component 6 ( C6 ), procollagen C-endopeptidase enhancer 2 ( Pcolce2 ), interleukin 22 receptor, alpha 2 ( Il22ra2 ), and T cell immunoglobulin and mucin domain containing 4 ( Timd4 ). Gene Ontology enrichment analysis support upregulation of cell cycle pathways and downregulation of immune system response in splenic cells. The liver transcriptome identified 27 significantly dysregulated genes with greater than a two-fold change in expression compared to wild-type littermates. Cd5l , Timd4 , C-C motif chemokine receptor 3 ( Ccr3 ), ADAM metallopeptidase domain 11 ( Adam11 ) and macrophage expressed 1 ( Mpeg1 ) were amongst those most significantly dysregulated. Enrichment analysis supported altered immune function with upregulation of sterol and steroid metabolic processes and downregulation of fatty acid biosynthesis and inflammatory and immune system responses. Although brain and spinal cord transcriptome profiles identified several genes significantly dysregulated in Nr1h3 mice compared to wild-type littermates (FDR<0.05), none presented greater than two-fold changes in gene expression. Discussion The analysis of the Nr1h3 p.Arg413Gln mouse model of MS suggests that the predominance of a pro-inflammatory over a healing or reparative phenotype, combined with deficiencies in myelination and remyelination, are the biological mechanisms implicated in the onset of MS and the development of a more severe progressive disease course observed in patients with NR1H3 mutations. Association of NR1H3 common variants with MS risk indicates that the disruption of these biological and immunological processes is not only informative for familial forms of disease but MS patients at large. Differences in transcriptome profiles underline the value of this model for the development and validation of novel therapeutic strategies and ultimately treatments with the potential to delay or even halt the onset of progressive MS and to ameliorate the severity of clinical symptoms.

Modeling the monosomy for the telomeric part of human chromosome 21 reveals haploinsufficient genes modulating the inflammatory and airway responses.

Modeling Partial Monosomy for Human Chromosome 21q11.2-q21.1 Reveals Haploinsufficient Genes Influencing Behavior and Fat Deposition

In vivo response to high-resolution variation of Tbx1 mRNA dosage.

Transcriptome analysis of the NR1H3 mouse model of multiple sclerosis reveals a pro-inflammatory phenotype with dysregulation of lipid metabolism and immune response genes

Divergent phenotypes in constitutive versus conditional mutant mouse models of Sifrim-Hitz-Weiss syndrome

Reciprocal Effects on Neurocognitive and Metabolic Phenotypes in Mouse Models of 16p11.2 Deletion and Duplication Syndromes

An Innovative CRISPR/Cas9 Mouse Model of Human Isolated Microtia Indicates the Potential Contribution of CNVs Near HMX1 Gene

Genetic variation in Mon1a affects protein trafficking and modifies macrophage iron loading in mice

Natural Functional Snps in Mir-155 Alter Its Expression Level, Blood Cell Counts, and Immune Responses

Genomic responses in mouse models poorly mimic human inflammatory diseases

Genetic determinants of micronucleus formation in vivo

Telomere function and regulation from mouse models to human ageing and disease

Host genetics and tumor environment determine the functional impact of neutrophils in mouse tumor models

Inherited deficiency of stress granule ZNFX1 in patients with monocytosis and mycobacterial disease

Cognitive and molecular characterization of the Ts66Yah murine model of Down syndrome: deepening on hippocampal changes associated with genotype and aging

Mutations in the non-coding RNU4ATAC gene affect the homeostasis and function of the Integrator complex

Human MCTS1-dependent translation of JAK2 is essential for IFN-γ immunity to mycobacteria

A mutant ASXL1-EHMT complex contributes to heterochromatin dysfunction in clonal hematopoiesis and chronic monomyelocytic leukemia

Analyzing Differences in Hematological and Immunological Characteristics Related to Common Gene Mutations in Myelodysplastic Syndromes

Myt1l haploinsufficiency leads to obesity and multifaceted behavioral alterations in mice

Pathological PNPase variants with altered RNA binding and degradation activity affect the phenotype of bacterial and human cell models